<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
  <channel>
    <title>Ando, Yuki (19..-....)</title>
    <description><![CDATA[ Biostatisticienne à la Pharmaceuticals and Medical Devices Agency (PMDA) du Japon (en 2013)

 ]]></description>
    <link>https://www.canal-u.tv/intervenants/ando-yuki-254010415</link>
    <lastBuildDate>Wed, 08 Jun 2022 17:08:39 +0100</lastBuildDate>
    <generator>Canal-U</generator>
    <language>fr</language>
        <itunes:category text="Education"></itunes:category>
    <itunes:author >Canal-U</itunes:author>
    <itunes:explicit >No</itunes:explicit>
    <itunes:owner >
      <itunes:name>Ando, Yuki (19..-....)</itunes:name>
      <itunes:email>contact@canal-u.tv</itunes:email>
    </itunes:owner>
          <item>
        <title>Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Lunch Session 3 : Regulatory viewpoint  (Yuki ANDO)</title>
        <link>https://www.canal-u.tv/62191</link>
                  <description><![CDATA[ MODIGLIANI Lunch Debate Session 3 - Saturday December 1st, 2012: HEART FAILURE TRIALISTS WORKSHOP LEARNING FROM RECENT TRIALS AND SHAPING THE FUTURE OF HEART FAILURE TRIALS Chairpersons: Alexandre MEBAZAA, Paris, FRA - Christopher O’CONNOR, Durham, USA Webcast: Daniela DOBRE, Nancy, FRA  Decreasing the very high mortality and rate of re-hospitalization associated with acute worsening HF is one of the most important unmet needs in cardiovascular medicine. Despite positive signals in Phase II stud ]]></description>
                          <pubDate>Thu, 21 Feb 2013 12:00:00 +0100</pubDate>
                <guid isPermaLink="false">https://www.canal-u.tv/62191</guid>
                  <enclosure url="https://vod.canal-u.tv/hls/cutms/,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.lunch.session.3.regulatory.viewpoint.yuki.ando._11414/modigliani_lunchsession3_yukiando_hd.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.lunch.session.3.regulatory.viewpoint.yuki.ando._11414/modigliani_lunchsession3_yukiando_std.mp4,cardiovascular.clinical.trialists.cvct.forum.a.paris.2012.lunch.session.3.regulatory.viewpoint.yuki.ando._11414/modigliani_lunchsession3_yukiando_bd.mp4,.urlset/master.m3u8" length="834" type="application/x-mpegurl" />
                      </item>
      </channel>
</rss>
